Clinical factors associated with resistance to microvascular complications in diabetic patients of extreme disease duration: The 50-year medalist study

Diabetes Care

Volumn 30, Issue 8, 2007, Pages 1995-1997

  Keenan, Hillary A ^a   Costacou, Tina ^b   Sun, Jennifer K ^a,c   Doria, Alessandro ^a   Cavellerano, Jerry ^a,c   Coney, Joseph ^a   Orchard, Trevor J ^b   Aiello, Lloyd Paul ^a,c   King, George L ^a,c  

^a JOSLIN DIABETES CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL FEATURE; DIABETES MELLITUS; DIABETIC MICROANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DISEASE DURATION; FEMALE; FOLLOW UP; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; QUESTIONNAIRE; RISK FACTOR; SELF REPORT;

AGED; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; DIABETIC RETINOPATHY; FEMALE; HUMANS; MALE; MIDDLE AGED; QUESTIONNAIRES;

EID: 34547691507     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc06-2222     Document Type: Article

References (17)

1. Zimmet P: The burden of type 2 diabetes: are we doing enough? Diabete Metab 6:S9-S18, 2003
2. Aiello LP, Gardner TW, King GL, Blankenship G, Cavallerano JD, Ferris FL, Klein R: Diabetic retinopathy. Diabetes Care 21:143-156, 1998
3. Krolewski M, Eggers PW, Warram JH: Magnitude of end-stage renal disease in IDDM: a 35 year follow-up study. Kidney In 50:2041-2046, 1996
4. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL: The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 102:520-526, 1984
5. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus: the Diabetes Control and Complications Trial Research Group. N Engl J Med 329: 977-986, 1993
6. Diabetes Controland Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group: Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study. JAMA 290:2159-2167, 2003
7. The Diabetes Control and Complications Trial Research Group: Clustering of long-term complications in families with diabetes in the diabetes control and complications trial. Diabetes 46:1829-1839, 1997
8. Cruickshanks KJ, Moss SE, Klein R, Klein BE: Physical activity and proliferative retinopathy in people diagnosed with diabetes before age 30 yr. Diabetes Care 15:1267-1272, 1992
9. Bain SC, Gill GV, Dyer PH, Jones AF, Murphy M, Jones KE, Smyth C, Barnett AH: Characteristics of type 1 diabetes of over 50 years duration (the Golden Years Cohort). Diabet Med 20:808-811, 2003
10. Ryan JR, Balodimos MC, Chazan BI, Root HF, Marble A, White P, Joslin AP: Quarter Century Victory Medal for Diabetes: a follow-up of patients one to 20 years later. Metabolism 19:493-501, 1970
11. Orchard TJ, Dorman JS, Maser RE, Becker DJ, Ellis D, LaPorte RE, Kuller LH, Wolfson SK Jr, Drash AL: Factors associated with avoidance of severe complications after 25 yr of IDDM: Pittsburgh Epidemiology of Diabetes Complications Study I. Diabetes Care 13:741-747, 1990
12. Orchard TJ, Dorman JS, Maser RE, Becker DJ, Drash AL, Ellis D, LaPorte RE, Kuller LH: Prevalence of complications in IDDM by sex and duration: Pittsburgh Epidemiology of Diabetes Complications Study II. Diabetes 39:1116-1124, 1990
13. Burke GL, Arnold AM, Bild DE, Cushman M, Fried LP, Newman A, Nunn C, Robbins J; CHS Collaborative Research Group: Factors associated with healthy aging: the cardiovascular health study. J Am Geriatr Soc 49:254-262, 2001
14. Poirier P, Giles TD, Bray GA, Hong Y, Stern JS, Pi-Sunyer FX, Eckel RH: Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association scientific statement on obesity and heart disease from the obesity committee of the council on nutrition, physical activity, and metabolism. Circulation 113:898-918, 2006
15. Nestruck AC, Davignon J: Risks for hyperlipidemia. Cardio Clin 4:47-56, 1986
16. Qasim A, Rader DJ: Human genetics of variation in high-density lipoprotein cholesterol. Curr Atheroscler Rep 8:198-205, 2006
17. Arias E: United States Life Tables, 2002: National Vital Statistics Reports. Vol. 53, no. 6. Hyattsville, MD, National Center for Health Statistics, 2004, Table 12